PM12: Photobiomodulation Therapy for the Treatment of Lower Extremity Stress Fractures in a Military Training Setting

Sponsor
Brooke Army Medical Center (U.S. Fed)
Overall Status
Not yet recruiting
CT.gov ID
NCT05843864
Collaborator
The Geneva Foundation (Other), Uniformed Services University of the Health Sciences (U.S. Fed)
122
1
2
16.1
7.6

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to compare photobiomodulation therapy (PBMT) in addition to standard of care in the treatment of tibial and metatarsal bone stress injuries in a military training setting.

Participants will all receive usual care and also be randomized to either active or sham photobiomodulation therapy. Effectiveness will be assessed based on time to return to duty and measures of pain and function.

  • Participants will receive care for a maximum of 6 weeks.

  • Participants will have follow-up through 4 months (or graduation/dismissal from training, whichever comes first).

Condition or Disease Intervention/Treatment Phase
  • Device: Photobiomodulation Therapy
  • Other: Sham Photobiomodulation Therapy
N/A

Detailed Description

Trainees with a diagnosis of medial tibial or metatarsal bone stress injuries/stress fracture will be recruited. Patients that consent and enroll will be randomized to receive standard of care physical therapy with (1) photobiomodulation therapy (PBMT) or (2) sham PBMT. Patients will receive treatment 3x per week for up to 6 weeks. The primary outcome will be the time to return to duty. Secondary outcomes will include additional time points (3-week, 6-week, 4-month) and Patient-Reported Outcomes Measurement Information System (PROMIS®) measures of pain and function, lower extremity imaging and various other measures outlined in the "Outcome Measure" section. Participants will be asked to report any mineral supplementation and to record daily activity in a log. Survival analysis will be used to evaluate return to duty between treatment arms with censoring beyond 4 months.

Longitudinal hierarchical/multilevel models with random effects will be used to evaluate differences between treatment arms for the relevant outcome measures. Sensitivity analyses will be conducted predicting change in measures at the final follow-up relative to baseline, and will use linear generalized additive models.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
122 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Utilizing Photobiomodulation Therapy for the Treatment of Lower Extremity Stress Fractures in a Military Training Setting
Anticipated Study Start Date :
May 1, 2023
Anticipated Primary Completion Date :
Mar 1, 2024
Anticipated Study Completion Date :
Sep 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Physical Therapy and Photobiomodulation Therapy

61 Participants will be randomized to this group and will receive Photobiomodulation Therapy (PBMT) in addition to standard physical therapy.

Device: Photobiomodulation Therapy
Photobiomodulation Therapy (PBMT) will be provided by a trained individual. Treatment will be delivered for approximately 10-16 minutes. Participants will then be instructed to rest for 5 minutes after the treatment.
Other Names:
  • Omnilux Plus 830
  • Sham Comparator: Physical Therapy and Sham Photobiomodulation Therapy

    61 Participants will be randomized to this group and will receive sham Photobiomodulation Therapy (PBMT) in addition to standard physical therapy.

    Other: Sham Photobiomodulation Therapy
    Sham Photobiomodulation Therapy (PBMT) will be provided by a trained to the some location and with the same contact time and frequency as the active intervention (PBMT). Participants will then be instructed to rest for 5 minutes after the treatment.

    Outcome Measures

    Primary Outcome Measures

    1. Time to Return to Duty [4 months]

      After treatment for stress fracture begins, the number of days before they return to duty will be counted.

    Secondary Outcome Measures

    1. Defense and Veteran's Pain Rating Scale (DVPRS) with supplemental questions [Weekly up to 6 weeks, 4 months]

      Pain will be captured weekly with this single-item assessment that utilizes a numerical rating scale (0-10, with 0 being "No Pain" and 10 being "As bad as it could be, nothing else matter") enhanced by functional word descriptors, color coding, and pictorial facial expressions matched to pain levels.

    2. Percussion Test [Baseline]

      The tester uses 2-3 fingers to firmly tap up and down on the injury area 3-4 times. Immediately afterwards, the individual provides a pain rating (Defense and Veterans Pain Rating Scale 0-10, with 0 being "No Pain" and 10 being "As bad as it could be, nothing else matter").

    3. Percussion Test [3 weeks]

      The tester uses 2-3 fingers to firmly tap up and down on the injury area 3-4 times. Immediately afterwards, the individual provides a pain rating (Defense and Veterans Pain Rating Scale 0-10, with 0 being "No Pain" and 10 being "As bad as it could be, nothing else matter").

    4. Percussion Test [6 weeks]

      The tester uses 2-3 fingers to firmly tap up and down on the injury area 3-4 times. Immediately afterwards, the individual provides a pain rating (Defense and Veterans Pain Rating Scale 0-10, with 0 being "No Pain" and 10 being "As bad as it could be, nothing else matter").

    5. Percussion Test [4 months]

      The tester uses 2-3 fingers to firmly tap up and down on the injury area 3-4 times. Immediately afterwards, the individual provides a pain rating (Defense and Veterans Pain Rating Scale 0-10, with 0 being "No Pain" and 10 being "As bad as it could be, nothing else matter").

    6. Hopping Test [Baseline]

      Participants will be asked to perform up to 10 hops as tolerated on their symptomatic leg(s). At the conclusion of the test, participants will be asked to provide a pain rating (Defense and Veterans Pain Rating Scale 0-10, with 0 being "No Pain" and 10 being "As bad as it could be, nothing else matter"). If they are unable to reach 10 hops due to pain that will be recorded as an "incomplete".

    7. Hopping Test [3 weeks]

      Participants will be asked to perform up to 10 hops as tolerated on their symptomatic leg(s). At the conclusion of the test, participants will be asked to provide a pain rating (Defense and Veterans Pain Rating Scale 0-10, with 0 being "No Pain" and 10 being "As bad as it could be, nothing else matter"). If they are unable to reach 10 hops due to pain that will be recorded as an "incomplete"

    8. Hopping Test [6 weeks]

      Participants will be asked to perform up to 10 hops as tolerated on their symptomatic leg(s). At the conclusion of the test, participants will be asked to provide a pain rating (Defense and Veterans Pain Rating Scale 0-10, with 0 being "No Pain" and 10 being "As bad as it could be, nothing else matter"). If they are unable to reach 10 hops due to pain that will be recorded as an "incomplete"

    9. Hopping Test [4 months]

      Participants will be asked to perform up to 10 hops as tolerated on their symptomatic leg(s). At the conclusion of the test, participants will be asked to provide a pain rating (Defense and Veterans Pain Rating Scale 0-10, with 0 being "No Pain" and 10 being "As bad as it could be, nothing else matter"). If they are unable to reach 10 hops due to pain that will be recorded as an "incomplete"

    10. Lower Extremity Functional Scale (LEFS) [Baseline]

      The LEFS is a self-reported assessment of physical function. It asks 20 questions with response options of "Extreme difficulty or unable to perform activity" (0), "Quite a bit of difficulty" (1), "Moderate difficulty" (2), "A little bit of difficulty" (3), "No difficulty" (4).

    11. Lower Extremity Functional Scale (LEFS) [3 weeks]

      The LEFS is a self-reported assessment of physical function. It asks 20 questions with response options of "Extreme difficulty or unable to perform activity" (0), "Quite a bit of difficulty" (1), "Moderate difficulty" (2), "A little bit of difficulty" (3), "No difficulty" (4).

    12. Lower Extremity Functional Scale (LEFS) [6 weeks]

      The LEFS is a self-reported assessment of physical function. It asks 20 questions with response options of "Extreme difficulty or unable to perform activity" (0), "Quite a bit of difficulty" (1), "Moderate difficulty" (2), "A little bit of difficulty" (3), "No difficulty" (4).

    13. Lower Extremity Functional Scale (LEFS) [4 months]

      The LEFS is a self-reported assessment of physical function. It asks 20 questions with response options of "Extreme difficulty or unable to perform activity" (0), "Quite a bit of difficulty" (1), "Moderate difficulty" (2), "A little bit of difficulty" (3), "No difficulty" (4).

    Other Outcome Measures

    1. Fredericson grading system [Baseline]

      Severity of the stress fracture is assessed from Magnetic Resonance Imaging by a radiologist. Severity is classified as Grade "1", "2", "3", "4a" or "4b", with "Grade 1" being the least severe.

    2. Fredericson grading system [6 week]

      Severity of the stress fracture is assessed from Magnetic Resonance Imaging by a radiologist. Severity is classified as Grade "1", "2", "3", "4a" or "4b", with "Grade 1" being the least severe.

    3. Fredericson grading system [4 months]

      Severity of the stress fracture is assessed from Magnetic Resonance Imaging by a radiologist. Severity is classified as Grade "1", "2", "3", "4a" or "4b", with "Grade 1" being the least severe.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    17 Years to 64 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • between ages 17-64 (inclusive) years old

    • Currently completing Advanced Individual Training (AIT) training at Fort Sam Houston and at least 6 weeks prior to graduation

    • Clinical diagnosis of metatarsal or medial tibial bone stress injury/stress fracture (unilateral or bilateral) by a healthcare provider based on accepted diagnostic criteria, with diagnostic imaging confirmation

    • Able to read and understand English language for consent purposes

    • Able to commit to study intervention and follow-up

    Exclusion Criteria:
    • Stress fracture to tibia that is not medial (e.g., anterior) or any location other than 5th metatarsal or medial tibia

    • Has already become a severe non-union bone stress injury/fracture

    • Received dry needling within the past 4 weeks

    • Received Platelet Rich Plasma (PRP) injection, corticosteroid injection, or prolotherapy within the past 3 months

    • Diagnosis of neuropathy affecting sensation to pain

    • Current or chronic sciatica (lumbosacral radiculopathy) resulting in chronic or intermittent lower extremity pain, numbness, or tingling (all below the knee)

    • Current or previous diagnosis of eating disorder (e.g., bulimia nervosa, anorexia nervosa, disordered eating, or other eating disorder not specified)

    • Diagnosis of porphyria (light induced allergy) or photosensitive eczema

    • Diagnosis of autoimmune disease (e.g., Lupus)

    • Albinism

    • Current use of anti-inflammatory steroids due to increased risk of Bone Stress Injury (BSI) with the past two weeks

    • Current use of medications associated with sensitivity to heat or light in the past five days (e.g., amiodarone, chlorpromazine, doxycycline, hydrochlorothiazide, nalidixic acid, naproxen, piroxicam, tetracycline, thioridazine, voriconazole)

    • Previous or current (within the past 2 years) use of Depo Provera

    • Current use of pacemaker

    • Tattoo in the area of treatment due to sensitivity to Photobiomodulation Therapy (PBMT)

    • Concurrent participation in another research study receiving treatment for metatarsal or medial tibial bone stress injury/stress fracture

    • Currently pregnant or plan to become pregnant during intervention period (safety of PBMT not established in pregnancy)

    • Current diagnosis or symptoms of amenorrhea (≥ 6 months without a menstrual period) or oligomenorrhea (only 4-9 menstrual periods in a year)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Brooke Army Medical Center San Antonio Texas United States 78219

    Sponsors and Collaborators

    • Brooke Army Medical Center
    • The Geneva Foundation
    • Uniformed Services University of the Health Sciences

    Investigators

    • Principal Investigator: Daniel Rhon, DSc, PhD, Uniformed Services University of the Health Sciences

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Dan Rhon, Director, Musculoskeletal Research in Primary Care Program, Brooke Army Medical Center
    ClinicalTrials.gov Identifier:
    NCT05843864
    Other Study ID Numbers:
    • C.2023.025
    First Posted:
    May 6, 2023
    Last Update Posted:
    May 6, 2023
    Last Verified:
    May 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Product Manufactured in and Exported from the U.S.:
    Yes
    Keywords provided by Dan Rhon, Director, Musculoskeletal Research in Primary Care Program, Brooke Army Medical Center
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 6, 2023